vs
Freshpet, Inc.（FRPT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Freshpet, Inc.的季度营收约是Orthofix Medical Inc.的1.3倍（$285.2M vs $219.9M），Freshpet, Inc.净利率更高（11.9% vs -1.0%，领先12.9%），Freshpet, Inc.同比增速更快（8.6% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $2.1M），过去两年Freshpet, Inc.的营收复合增速更高（12.9% vs 8.0%）
Freshpet, Inc.是一家美国宠物食品企业，主打鲜制猫粮、狗粮产品，相关产品需冷藏保存，目前在纳斯达克上市，股票代码为FRPT。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
FRPT vs OFIX — 直观对比
营收规模更大
FRPT
是对方的1.3倍
$219.9M
营收增速更快
FRPT
高出6.6%
2.0%
净利率更高
FRPT
高出12.9%
-1.0%
自由现金流更多
OFIX
多$14.8M
$2.1M
两年增速更快
FRPT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $285.2M | $219.9M |
| 净利润 | $33.8M | $-2.2M |
| 毛利率 | 43.3% | 71.1% |
| 营业利润率 | 15.6% | 0.2% |
| 净利率 | 11.9% | -1.0% |
| 营收同比 | 8.6% | 2.0% |
| 净利润同比 | 86.6% | 92.4% |
| 每股收益（稀释后） | $0.71 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRPTOFIX
| Q4 25 | $285.2M | $219.9M | ||
| Q3 25 | $288.8M | $205.6M | ||
| Q2 25 | $264.7M | $203.1M | ||
| Q1 25 | $263.2M | $193.6M | ||
| Q4 24 | $262.7M | $215.7M | ||
| Q3 24 | $253.4M | $196.6M | ||
| Q2 24 | $235.3M | $198.6M | ||
| Q1 24 | $223.8M | $188.6M |
净利润FRPTOFIX
| Q4 25 | $33.8M | $-2.2M | ||
| Q3 25 | $101.7M | $-22.8M | ||
| Q2 25 | $16.4M | $-14.1M | ||
| Q1 25 | $-12.7M | $-53.1M | ||
| Q4 24 | $18.1M | $-29.1M | ||
| Q3 24 | $11.9M | $-27.4M | ||
| Q2 24 | $-1.7M | $-33.4M | ||
| Q1 24 | $18.6M | $-36.0M |
毛利率FRPTOFIX
| Q4 25 | 43.3% | 71.1% | ||
| Q3 25 | 39.5% | 72.2% | ||
| Q2 25 | 40.9% | 68.7% | ||
| Q1 25 | 39.4% | 62.8% | ||
| Q4 24 | 42.5% | 69.0% | ||
| Q3 24 | 40.4% | 68.7% | ||
| Q2 24 | 39.9% | 67.8% | ||
| Q1 24 | 39.4% | 67.5% |
营业利润率FRPTOFIX
| Q4 25 | 15.6% | 0.2% | ||
| Q3 25 | 8.6% | -8.3% | ||
| Q2 25 | 6.7% | -7.9% | ||
| Q1 25 | -4.4% | -25.2% | ||
| Q4 24 | 7.4% | -5.3% | ||
| Q3 24 | 4.7% | -9.6% | ||
| Q2 24 | -0.7% | -12.5% | ||
| Q1 24 | 3.8% | -15.6% |
净利率FRPTOFIX
| Q4 25 | 11.9% | -1.0% | ||
| Q3 25 | 35.2% | -11.1% | ||
| Q2 25 | 6.2% | -6.9% | ||
| Q1 25 | -4.8% | -27.4% | ||
| Q4 24 | 6.9% | -13.5% | ||
| Q3 24 | 4.7% | -13.9% | ||
| Q2 24 | -0.7% | -16.8% | ||
| Q1 24 | 8.3% | -19.1% |
每股收益（稀释后）FRPTOFIX
| Q4 25 | $0.71 | $-0.05 | ||
| Q3 25 | $1.86 | $-0.57 | ||
| Q2 25 | $0.33 | $-0.36 | ||
| Q1 25 | $-0.26 | $-1.35 | ||
| Q4 24 | $0.35 | $-0.76 | ||
| Q3 24 | $0.24 | $-0.71 | ||
| Q2 24 | $-0.03 | $-0.88 | ||
| Q1 24 | $0.37 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $278.0M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $450.0M |
| 总资产 | $1.8B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FRPTOFIX
| Q4 25 | $278.0M | $82.0M | ||
| Q3 25 | $274.6M | $62.9M | ||
| Q2 25 | $243.7M | $65.6M | ||
| Q1 25 | $243.7M | $58.0M | ||
| Q4 24 | $268.6M | $83.2M | ||
| Q3 24 | $274.6M | $30.1M | ||
| Q2 24 | $251.7M | $26.4M | ||
| Q1 24 | $257.9M | $27.0M |
总债务FRPTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益FRPTOFIX
| Q4 25 | $1.2B | $450.0M | ||
| Q3 25 | $1.2B | $442.5M | ||
| Q2 25 | $1.1B | $458.3M | ||
| Q1 25 | $1.0B | $458.3M | ||
| Q4 24 | $1.1B | $503.1M | ||
| Q3 24 | $1.0B | $525.9M | ||
| Q2 24 | $995.8M | $546.0M | ||
| Q1 24 | $977.8M | $570.3M |
总资产FRPTOFIX
| Q4 25 | $1.8B | $850.6M | ||
| Q3 25 | $1.7B | $832.6M | ||
| Q2 25 | $1.6B | $837.2M | ||
| Q1 25 | $1.6B | $823.1M | ||
| Q4 24 | $1.6B | $893.3M | ||
| Q3 24 | $1.5B | $867.9M | ||
| Q2 24 | $1.5B | $882.0M | ||
| Q1 24 | $1.5B | $906.0M |
负债/权益比FRPTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $2.1M | $16.8M |
| 自由现金流率自由现金流/营收 | 0.7% | 7.6% |
| 资本支出强度资本支出/营收 | 18.6% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.63× | — |
| 过去12个月自由现金流最近4个季度 | $12.4M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流FRPTOFIX
| Q4 25 | $55.1M | $27.7M | ||
| Q3 25 | $66.8M | $12.4M | ||
| Q2 25 | $33.9M | $11.6M | ||
| Q1 25 | $4.8M | $-18.4M | ||
| Q4 24 | $50.4M | $23.7M | ||
| Q3 24 | $56.1M | $11.7M | ||
| Q2 24 | $42.4M | $9.0M | ||
| Q1 24 | $5.4M | $-18.6M |
自由现金流FRPTOFIX
| Q4 25 | $2.1M | $16.8M | ||
| Q3 25 | $31.6M | $2.5M | ||
| Q2 25 | $445.0K | $4.5M | ||
| Q1 25 | $-21.7M | $-25.1M | ||
| Q4 24 | $-7.9M | $15.2M | ||
| Q3 24 | $22.1M | $6.3M | ||
| Q2 24 | $-5.9M | $-360.0K | ||
| Q1 24 | $-41.1M | $-29.1M |
自由现金流率FRPTOFIX
| Q4 25 | 0.7% | 7.6% | ||
| Q3 25 | 10.9% | 1.2% | ||
| Q2 25 | 0.2% | 2.2% | ||
| Q1 25 | -8.2% | -13.0% | ||
| Q4 24 | -3.0% | 7.0% | ||
| Q3 24 | 8.7% | 3.2% | ||
| Q2 24 | -2.5% | -0.2% | ||
| Q1 24 | -18.3% | -15.4% |
资本支出强度FRPTOFIX
| Q4 25 | 18.6% | 4.9% | ||
| Q3 25 | 12.2% | 4.8% | ||
| Q2 25 | 12.6% | 3.5% | ||
| Q1 25 | 10.1% | 3.5% | ||
| Q4 24 | 22.2% | 4.0% | ||
| Q3 24 | 13.4% | 2.7% | ||
| Q2 24 | 20.5% | 4.7% | ||
| Q1 24 | 20.8% | 5.6% |
现金转化率FRPTOFIX
| Q4 25 | 1.63× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 2.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.78× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRPT
| Sales Channel Grocery Mass International And Digital | $228.4M | 80% |
| Sales Channel Pet Specialty And Club | $56.8M | 20% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
